<DOC>
	<DOCNO>NCT00556426</DOCNO>
	<brief_summary>This study design assess safety retrieval Bard Recovery® G2® Filter System . The G2 filter FDA-cleared device inferior vena caval interruption patient pulmonary thromboembolism .</brief_summary>
	<brief_title>Prospective , Multi-center , Single-arm Study Assess Safety Retrieval Recovery G2 Filter .</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>The patient temporary , increase risk pulmonary embolism require caval interruption The patient implant filter IVC superior vena cava ( SVC ) The patient duplicate leftsided IVC The patient know untreatable uncontrollable malignancy The patient severe spinal deformity The patient creatinine &gt; 2.0 mg/dl The patient life expectancy &lt; 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Venous Thromboembolic Disease</keyword>
	<keyword>IVC Filter</keyword>
	<keyword>Pulmonary Embolism</keyword>
</DOC>